US to export AstraZeneca COVID-19 vaccines for global use 

The United States will share COVID-19 vaccines from AstraZeneca with the rest of the world once it passes federal safety expectations, according to The Associated Press.   

Around 60 million doses of the company’s vaccine are expected to be exported globally, the White House told the AP.   

“Given the strong portfolio of vaccines that the U.S. already has and that have been authorized by the FDA, and given that the AstraZeneca vaccine is not authorized for use in the U.S., we do not need to use the AstraZeneca vaccine here during the next several months,” White House COVID-19 coordinator Jeff Zients told the AP. “Therefore the U.S. is looking at options to share the AstraZeneca doses with other countries as they become available.”  

RELATED: UK: Benefits outweigh risks for AstraZeneca despite 7 deaths

In March, the Biden administration provided 4 million doses of the AstraZeneca COVID-19 vaccine to Mexico and Canada.   

Over 53% of adults in the U.S. have received at least one dose of the three available vaccines from Pfizer, Moderna and Johnson & Johnson.   

The AstraZeneca vaccine was not approved yet by the FDA, as it has not filed for an emergency-use authorization, according to reports.   

Latest in News


Prince Still Reigns: Late Artist to be Awarded Congressional Gold Medal


Parole Denied for Man Convicted of Killing Michael Jordan’s Father

Jelani Day


‘Justice for Jelani Day’: County Coroner Determines Cause of Death


Female DC Officers Speak Out After Filing Lawsuit Against Department

Muhammad Ali


Nico Ali Walsh, Muhammad Ali’s Grandson, Wins Second Professional Fight


Ken Griffey Jr. Joins Seattle Mariners Ownership

Police Deaths Use of Force Legislation


Judicial Inquiry Into Eric Garner’s Death Begins in New York


Rapper Freeway Loses His Daughter to Cancer